These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3438618)

  • 81. Randomised controlled trials and retrospective controls.
    Doll R; Peto R
    Br Med J; 1980 Jan; 280(6206):44. PubMed ID: 7357264
    [No Abstract]   [Full Text] [Related]  

  • 82. Self-designing trial combined with classical group sequential monitoring.
    Yin G; Shen Y
    J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
    Fiore LD; Deykin D
    Cardiol Clin; 1994 Aug; 12(3):451-76. PubMed ID: 7805079
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Increasing the sample size at interim for a two-sample experiment without Type I error inflation.
    Dunnigan K; King DW
    Pharm Stat; 2010; 9(4):280-7. PubMed ID: 19764040
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Controlled clinical trials in cancer research.
    Skovlund E
    Acta Oncol; 1996; 35 Suppl 8():27-33. PubMed ID: 9073046
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Interim analysis: the alpha spending function approach.
    DeMets DL; Lan KK
    Stat Med; 1994 Jul 15-30; 13(13-14):1341-52; discussion 1353-6. PubMed ID: 7973215
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Strategies for changing the test statistic during a clinical trial.
    Lawrence J
    J Biopharm Stat; 2002 May; 12(2):193-205. PubMed ID: 12413240
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Designs for group sequential tests.
    Fleming TR; Harrington DP; O'Brien PC
    Control Clin Trials; 1984 Dec; 5(4):348-61. PubMed ID: 6518769
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Monitoring rules for stopping accrual in comparative survival studies.
    Rubinstein LV; Gail MH
    Control Clin Trials; 1982 Dec; 3(4):325-43. PubMed ID: 7160190
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Monitoring a clinical trial with multiple hypotheses concerning the treatment effect on a single primary endpoint.
    Denne JS; Koch GG
    Stat Med; 2001 Oct; 20(19):2801-12; discussion 2813-4. PubMed ID: 11568939
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Tricks and traps in dental clinical trials.
    Carlos JP
    Community Dent Oral Epidemiol; 1985 Apr; 13(2):79-81. PubMed ID: 3857153
    [No Abstract]   [Full Text] [Related]  

  • 92. p-value and power computations in multiple look trials.
    Peace KE; Schriver RC
    J Chronic Dis; 1987; 40(1):23-30. PubMed ID: 3805230
    [TBL] [Abstract][Full Text] [Related]  

  • 93. How study design affects outcomes in comparisons of therapy. I: Medical.
    Colditz GA; Miller JN; Mosteller F
    Stat Med; 1989 Apr; 8(4):441-54. PubMed ID: 2727468
    [TBL] [Abstract][Full Text] [Related]  

  • 94. An investigation of the adequacy of a randomization.
    Wahrendorf J; Blettner M; Edler L
    Control Clin Trials; 1985 Dec; 6(4):249-58. PubMed ID: 4075804
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Sample size graphs for "proving the null hypothesis".
    Blackwelder WC; Chang MA
    Control Clin Trials; 1984 Jun; 5(2):97-105. PubMed ID: 6744888
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A method of assigning scores to the components of a composite outcome: an example from the MITI trial.
    Hallstrom AP; Litwin PE; Weaver WD
    Control Clin Trials; 1992 Apr; 13(2):148-55. PubMed ID: 1316829
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Loss of patients in clinical trials that measure long-term survival following myocardial infarction.
    Bhaskar R; Reitman D; Sacks HS; Smith H; Chalmers TC
    Control Clin Trials; 1986 Jun; 7(2):134-48. PubMed ID: 3743092
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Exemplary data: sample size and power in the design of event-time clinical trials.
    Goldman AI; Hillman DW
    Control Clin Trials; 1992 Aug; 13(4):256-71. PubMed ID: 1330432
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Should Clinical Trials Be Terminated Early?
    Streiner DL
    Clin Ther; 2019 Sep; 41(9):1889-1891. PubMed ID: 31351677
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Methods for clarifying criteria for study continuation at interim analysis.
    Wiener LE; Ivanova A; Koch GG
    Pharm Stat; 2020 Sep; 19(5):720-732. PubMed ID: 32338443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.